Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis.

ABSTRACT:

SUBMITTER: Papadopoulou C 

PROVIDER: S-EPMC6391598 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature